本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

eFFECTOR Therapeutics, Inc.

0.0002
0.0000
成交量:283.00
成交额:0.06
市值:940.88
市盈率:0.00
高:0.0002
开:0.0002
低:0.0002
收:0.0002
52周最高:0.0500
52周最低:0.0000
股本:470.44万
流通股本:458.21万
量比:1.21
换手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):-12.4244
每股收益(LYR):-16.3748
净资产收益率:-946.56%
总资产收益率:-83.33%
市净率:0.00
市盈率(LYR):0.00

数据加载中...

2024/07/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/19

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/25

重要事件披露

Form 8-K - Current report
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/04

重要事件披露

Form 8-K - Current report
2024/03/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]